93 related articles for article (PubMed ID: 29511039)
1. Metformin Is Not Associated with Incidence Risk of Non-Hodgkin Lymphomas among Diabetic Patients.
Ye X; Zhang G; Righolt C; Johnston JB; Banerji V; Gibson SB; Mahmud SM
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):610-612. PubMed ID: 29511039
[No Abstract] [Full Text] [Related]
2. Associations between statin use and risk of non-Hodgkin lymphomas by subtype.
Ye X; Zhang G; Righolt C; Johnston JB; Banerji V; Gibson SB; Mahmud SM
Int J Cancer; 2018 Aug; 143(4):971-979. PubMed ID: 29524215
[TBL] [Abstract][Full Text] [Related]
3. Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes.
Tseng CH
Diabetes Metab; 2019 Oct; 45(5):458-464. PubMed ID: 31129317
[TBL] [Abstract][Full Text] [Related]
4. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
5. Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case-control study within Italian healthcare utilization databases.
Franchi M; Asciutto R; Nicotra F; Merlino L; La Vecchia C; Corrao G; Bosetti C
Eur J Cancer Prev; 2017 May; 26(3):225-231. PubMed ID: 27222938
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
[TBL] [Abstract][Full Text] [Related]
7. Metformin and the risk of renal cell carcinoma: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Eur J Cancer Prev; 2017 May; 26(3):257-262. PubMed ID: 26945286
[TBL] [Abstract][Full Text] [Related]
8. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
9. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
10. The dose-response relationship between tobacco smoking and the risk of lymphomas: a case-control study.
Taborelli M; Montella M; Libra M; Tedeschi R; Crispo A; Grimaldi M; Dal Maso L; Serraino D; Polesel J
BMC Cancer; 2017 Jun; 17(1):421. PubMed ID: 28622762
[TBL] [Abstract][Full Text] [Related]
11. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.
Sehdev A; Shih YC; Vekhter B; Bissonnette MB; Olopade OI; Polite BN
Cancer; 2015 Apr; 121(7):1071-8. PubMed ID: 25424411
[TBL] [Abstract][Full Text] [Related]
12. Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study.
Lankes HA; Fought AJ; Evens AM; Weisenburger DD; Chiu BC
Cancer Causes Control; 2009 Jul; 20(5):517-23. PubMed ID: 19011978
[TBL] [Abstract][Full Text] [Related]
13. Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Am J Gastroenterol; 2012 Apr; 107(4):620-6. PubMed ID: 22290402
[TBL] [Abstract][Full Text] [Related]
14. The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Läärä E; Hinkula M
BJOG; 2018 Jul; 125(8):1001-1008. PubMed ID: 29412502
[TBL] [Abstract][Full Text] [Related]
15. Metformin use reduced the overall risk of cancer in diabetic patients: A study based on the Korean NHIS-HEALS cohort.
Kim YS; Choi EA; Lee JW; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kang HT; Kim J
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1714-1722. PubMed ID: 32753274
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of vitamin B(12) deficiency in patients receiving metformin.
Ting RZ; Szeto CC; Chan MH; Ma KK; Chow KM
Arch Intern Med; 2006 Oct; 166(18):1975-9. PubMed ID: 17030830
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
[TBL] [Abstract][Full Text] [Related]
18. Tobacco use and non-Hodgkin lymphoma: results from a population-based case-control study in the San Francisco Bay Area, California.
Bracci PM; Holly EA
Cancer Causes Control; 2005 May; 16(4):333-46. PubMed ID: 15953976
[TBL] [Abstract][Full Text] [Related]
19. Insulin use increases risk of asthma but metformin use reduces the risk in patients with diabetes in a Taiwanese population cohort.
Chen CZ; Hsu CH; Li CY; Hsiue TR
J Asthma; 2017 Dec; 54(10):1019-1025. PubMed ID: 28135899
[TBL] [Abstract][Full Text] [Related]
20. Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms.
Kristensen KL; Pottegård A; Hallas J; Rasmussen LM; Lindholt JS
J Vasc Surg; 2017 Sep; 66(3):768-774.e2. PubMed ID: 28506478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
